WELLS FARGO & COMPANY/MN - AXOVANT GENE THERAPIES LTD ownership

Back to all holdings Add to watchlist

AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 50 filers reported holding AXOVANT GENE THERAPIES LTD in Q3 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of AXOVANT GENE THERAPIES LTD
ValueSharesWeighting
Q3 2020$1,000–1310.0%0.00%–
Q2 2020$0–1310.0%0.00%–
Q1 2020$0
-100.0%
131
-58.8%
0.00%–
Q4 2019$2,0000.0%3180.0%0.00%–
Q3 2019$2,0000.0%318
+1.9%
0.00%–
Q2 2019$2,000–312–0.00%–
 Download
Other shareholders

There were no reported owners of AXOVANT GENE THERAPIES LTD in Q3 2019.

NameSharesValueWeighting ↓
View complete list of AXOVANT GENE THERAPIES LTD shareholders